Inhibition of polymerase chain reaction: Pathogen-specific controls are better than human gene amplification
Authors:
Open Access
- 27 September 2019
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (9) , e0219276
Abstract
PCR inhibition is frequent in medical microbiology routine practice and may lead to false-negative results; however there is no consensus on how to detect it. Pathogen-specific and human gene amplifications are widely used to detect PCR inhibition. We aimed at comparing the value of PCR inhibitor detection using these two methods. We analysed Cp shifts (ΔCp) obtained from qPCRs targeting either the albumin gene or the pathogen-specific sequence used in two laboratory-developed microbiological qPCR assays. 3152 samples including various matrixes were included. Pathogen-specific amplification and albumin qPCR identified 62/3152 samples (2.0%), and 409/3152 (13.0%) samples, respectively, as inhibited. Only 16 samples were detected using both methods. In addition, the use of the Youden's index failed to determine adequate Cp thresholds for albumin qPCR, even when we distinguished among the different sample matrixes. qPCR targeting the albumin gene therefore appears not adequate to identify the presence of PCR inhibitors in microbiological PCR assays. Our data may be extrapolated to other heterologous targets and should discourage their use to assess the presence of PCR inhibition in microbiological PCR assays.Keywords
All Related Versions
This publication has 25 references indexed in Scilit:
- Novel Interpretation of Molecular Diagnosis of Congenital Toxoplasmosis According to Gestational Age at the Time of Maternal InfectionJournal of Clinical Microbiology, 2012
- Degree and frequency of inhibition in a routine real-time PCR detecting Pneumocystis jirovecii for the diagnosis of Pneumocystis pneumonia in TurkeyJournal of Medical Microbiology, 2011
- Diversity and evolution of methods and practices for the molecular diagnosis of congenital toxoplasmosis in France: a 4-year surveyClinical Microbiology and Infection, 2010
- MIQE précis: Practical implementation of minimum standard guidelines for fluorescence-based quantitative real-time PCR experimentsBMC Molecular Biology, 2010
- Differential susceptibility of PCR reactions to inhibitors: an important and unrecognised phenomenonBMC Research Notes, 2008
- Development of a multiple internal control for clinical diagnostic real-time amplification assaysFEMS Immunology & Medical Microbiology, 2006
- Quantification of Leishmania infantum DNA by a Real-Time PCR Assay with High SensitivityJournal of Clinical Microbiology, 2004
- Comparison of Two Widely Used PCR Primer Systems for Detection of Toxoplasma in Amniotic Fluid, Blood, and TissuesJournal of Clinical Microbiology, 2004
- Purification and Characterization of PCR-Inhibitory Components in Blood CellsJournal of Clinical Microbiology, 2001
- Prenatal Diagnosis of Congenital Toxoplasmosis with a Polymerase-Chain-Reaction Test on Amniotic FluidNew England Journal of Medicine, 1994